The increase in authorized shares should give leverage with BP for licensing on our terms, even if shares not sold.
If terms are not agreeable with BP, we retain ability to conduct activities necessary for further development without BP money.
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-